Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Design Therapeutics, Inc.

Get SEC filing alerts via email and in your feed for Design Therapeutics, Inc.

DSGN

Design Therapeutics, Inc.

Latest news & discussion for Design Therapeutics, Inc.:

1
1
Design Therapeutics, Inc. Design Therapeutics Reports $49.6 Million Net Loss for 2024, Decreased Operating Expenses

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
Design Therapeutics, Inc. Design Therapeutics Reports Q3 2024 Financial Results, Advances GeneTACTM Molecule Development

Via official filing (AI summary) | 5 months ago | 0 comments